ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents by Elia, Josephine et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Child and Adolescent Psychiatry and 
Mental Health
Open Access Research
ADHD characteristics: I. Concurrent co-morbidity patterns in 
children & adolescents
Josephine Elia*1,2, Paul Ambrosini3 and Wade Berrettini2
Address: 1Department of Child and Adolescent Psychiatry, The Children's Hospital of Philadelphia, Philadelphia, PA, USA, 2Department of 
Psychiatry, The University of Pennsylvania, Philadelphia, PA, USA and 3Department of Psychiatry, Drexel University College of Medicine, 
Philadelphia, PA, USA
Email: Josephine Elia* - elia@email.chop.edu; Paul Ambrosini - paul.ambrosini@DrexelMed.edu; 
Wade Berrettini - wadeb@mail.med.upenn.edu
* Corresponding author    
Abstract
Objective: 342 Caucasian subjects with attention deficit/hyperactivity disorder (ADHD) were
recruited from pediatric and behavioral health clinics for a genetic study. Concurrent comorbidity
was assessed to characterize the clinical profile of this cohort.
Methods: Subjects 6 to 18 years were diagnosed with the Schedule for Affective Disorders &
Schizophrenia for School aged Children (K-SADS-P IVR).
Results: The most prevalent diagnoses co-occurring with ADHD were Oppositional Defiant
Disorder (ODD) (40.6%), Minor Depression/Dysthymia (MDDD) (21.6%), and Generalized
Anxiety Disorder (GAD) (15.2%). In Inattentive ADHD (n = 106), 20.8% had MDDD, 20.8% ODD,
and 18.6% GAD; in Hyperactive ADHD (n = 31) 41.9% had ODD, 22.2% GAD, and 19.4% MDDD.
In Combined ADHD, (n = 203), 50.7% had ODD, 22.7% MDDD and 12.4% GAD. MDDD and GAD
were equally prevalent in the ADHD subtypes but, ODD was significantly more common among
Combined and Hyperactive ADHD compared to Inattentive ADHD. The data suggested a
subsample of Irritable prepubertal children exhibiting a diagnostic triad of ODD, Combined ADHD,
and MDDD may account for the over diagnosing of Bipolar Disorder.
Conclusion: Almost 2/3rd of ADHD children have impairing comorbid diagnoses; Hyperactive
ADHD represents less than 10% of an ADHD sample; ODD is primarily associated with
Hyperactive and Combined ADHD; and, MDDD may be a significant morbidity for ADHD youths
from clinical samples.
Background
The primary goal of this report is to characterize the con-
current comorbidy patterns identified in a clinical sample
of ADHD subjects recruited for this genetic study. If more
homogenous comorbid ADHD subtypes are identified,
there is the potential for their validation through their
genetic characteristics. In any assessment of psychopa-
thology using standardized diagnostic interview sched-
ules, comorbidity is the rule however it is infrequently
considered in genetic studies. Concurrent comorbidity
means the disorders are present at the same time of assess-
ment as opposed to lifetime comorbidity which implies at
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any time over one's life. Comorbidity also can be classi-
fied into two broad patterns, homotypic or heterotypic
[1]. These characteristics refer, respectively, to the continu-
ity of a diagnostic pattern or the emergence of different
diagnostic patterns over a lifetime. For ADHD these types
of comorbidity could be represented by residual ADHD in
adults or the emergence of an affective syndrome at some
time in the course of ADHD. The relevance of these issues
for the present study is that the focus of the genetic analy-
sis of ADHD must consider the comorbid patterns of
ADHD itself. It may be that the "true" syndrome is actu-
ally reflected by a specific comorbid pattern [2]. Only by
more clearly defining the ADHD construct will there be
any success in identifying true genetic/biological markers
for this disorder [3].
Reports of comorbidity in ADHD include both commu-
nity and clinic samples. These are not compatible patient
pools because of the biased referral patterns and the
increased rates of disorder in any clinical group. Further-
more, only with a general population sample can a true
base rate of a disorder be calculated and comorbid exces-
sive identified [2]. Reported comorbid rates in ADHD are
substantial [4] yet prevalence figures frequently reflect epi-
demiological samples or life times rates within clinical
groups. Other large clinical samples such as the MTA
study [5] only included those with ADHD combined sub-
type ages 7 to 9.9. Nonetheless over 2/3rd of the MTA sam-
ple had concurrent comorbid disorders identified with a
parental DISC interview.
Angold et al's [1] extensive review of community studies
of comorbidity quantify the excess rates of comorbid con-
ditions in ADHD by calculating the odds ratio of the
major co-occurring disorders. They noted that the odds
ratios for ADHD-ODD/CD, ADHD-depression, and
ADHD-anxiety were 10.7, 5.5, and 3.0 respectively, sug-
gesting that comorbidity is not due to referral bias that
might be expected in clinical samples. Mood disorders
may be high in preadolescent ADHD regardless of referral
source [6] and this may be a heterotypic comorbid pattern
particularly in girls [7]. However, case ascertainment, def-
initions and assessment methodology, and comparison
control groups chosen must be considered in order to
understand the true significance of these findings.
Comorbidity rates are dependent on the assessment
methodology. In assessing ADHD children Biederman's
group [6,8] has relied on the K-SADS-E [9] that measures
current and life time disorders. The DISC utilized in the
MTA study [10] measures past 6 months for all disorders
except for CD which is for 12 months. The DICA measures
current and lifetime rates; however this distinction is not
differentiated in published reports [11,12]. Various symp-
tom rating scales such as the CBCL (rates symptoms now
or within past 6 months) or the Devereux Scales of Mental
Disorders (measures symptoms during past four weeks)
[13] have also been utilized to evaluate ADHD comorbid-
ity. Some clinical studies have used combinations of diag-
nostic interviews and rating scales [14,15]. Adult and
follow-up studies of ADHD have followed a similar pat-
tern using combinations of diagnostic and rating instru-
ments which again assess current, lifetime, or time specific
intervals. Introducing genetic data to validate comorbid
ADHD subtypes therefore, must be clear about the quali-
tative aspect of the comorbid data set. The genetic associ-
ations thus may be on a heterotypic/homotypic or
concurrent/lifetime pattern.
Methods
Participants
This report describes participants from an ongoing ADHD
genetic study aiming to recruiting 500 parents/child triads
with one or more ADHD probands. The sample currently
consists of 342 children and adolescents from 302 fami-
lies (33 families with 2 siblings and 6 families with 3 sib-
lings for a total of 342 children). All subjects were North-
American of European descent. Other groups were
excluded because haplotype frequencies can vary substan-
tially across major world populations [16] lowering
power of the study to detect genetic association if multiple
groups were included. This protocol was approved by the
Institutional Review Boards of The Children's Hospital of
Philadelphia and the University of Pennsylvania School
of Medicine. Parents provided consent and children
assent.
Procedures
Families were recruited from general pediatric clinics as
well as behavioral health clinics in the Philadelphia area.
Phone screenings were conducted to verify initial inclu-
sion criteria of age range between 6 and 18, presence of
ADHD symptoms, Caucasian of European descent, avail-
ability and willingness to participate in a genetic study
from both biological parents. Phone screenings also iden-
tified exclusionary criteria that included prematurity (< 36
weeks), mental retardation, major medical (excluding
asthma) neurological disorders (e.g. seizures, fetal alcohol
syndrome, plumbism) and neuropsychiatric disorders
such as pervasive developmental disorder, psychoses,
bipolar disorder, major depressive disorder with symp-
toms starting prior to ADHD or where ADHD symptoms
occurred primarily during depressed episodes. All anxiety
disorders were included. Children with documented IQ
scores < 75 were excluded as were children with histories
suggestive of mental retardation or inability to compre-
hend or complete the K-SADS.
Subjects who passed the phone screen proceeded with the
K-SADS evaluation. Twelve subjects were excluded fromChild and Adolescent Psychiatry and Mental Health 2008, 2:15 http://www.capmh.com/content/2/1/15
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the study after completing the diagnostic interview: Three
subjects did not have impairing ADHD symptoms, 2 sub-
jects met ADHD criteria primarily during a Major Depres-
sion and 2 subjects during a Generalized Anxiety
Disorder, 1 subject with ADHD and Adjustment Disorder
thought to significantly contribute to ADHD symptoms, 1
subject with ADHD and mild psychotic symptoms, 1 sub-
ject each with Cyclothymia, Bipolar Disorder and absence
seizures. Siblings meeting inclusion and exclusion criteria
were also invited to participate in the study, but their par-
ticipation was not required.
Measures
A child psychiatrist (JE) assessed diagnostic status by
administering a K-SADS P-IVR interview to the parent(s)
and child separately [9]. This semi-structured interview
provides diagnoses occurring within the last twelve
months of the present episode (PE) and for the last week
(LW). It is keyed to the Research Diagnostic Criteria
(RDC) [17] for those syndromes similar in youths and
adults. All other diagnoses are DSM IIIR/IV [18] based and
were made excluding the DSM diagnostic hierarchical
requirements. The K-SADS-P IVR diagnostic domain is
listed in Table 1. The primary diagnostician was trained in
the K-SADS administration by a clinician (PJA) with
extensive experience with this semi-structured interview.
Intraclass correlations (ICC) between these raters for the
diagnostic symptoms of the major disorders was assessed
through videotape reviews. All ICC values were highly sig-
nificant with the following ranges: affective disorders 0.74
– 0.85; anxiety disorder 0.75 – 0.92; ADHD: 0.82; ODD:
0.80.
The K-SADS IVR records Irritability as a symptom inde-
pendent of Depressed Mood. Irritability/Anger (subjec-
tive) was added as a third primary symptom of major
depression to verify whether it was synonymous to
depressed mood. This allows diagnosing an "Irritable
Affective Disorder" which is a RDC or DSM defined
depressive disorder where irritability replaces depressed
mood or pervasive anhedonia as the cardinal symptom.
For this study, Minor Depression (MD) and Dysthymic
Disorder (DD) are combined into a variable labeled
MDDD. Additional overall diagnostic variables were cre-
ated for Any Anxiety Disorder (AnyAD) and for Any
Depressive Disorder (AnyDep). The four main ADHD
subtypes are labeled ADDI (Inattentive ADHD), ADDH
(Hyperactive ADHD), ADDC (Combined ADHD), and
ADDN (ADHD NOS).
Cognitive ability was quantified by reviewing reports of
past IQ assessments. Children not previously tested were
Table 1: Diagnostic domain of K-SADS IVR
Affective Disorders Anxiety Disorders Behavior Disorders
Major Depressive Avoidant Disorder(AD) Oppositional Defiant Disorder(ODD)
Disorder(MDD) Generalized Anxiety Disruptive Behavior Disorder NOS
MDD, endogenous Disorder(GAD)
MDD, psychotic Overanxious Disorder(OAD) Attention Deficit-Hyperactivity
Irritable MDD Post Traumatic Stress Disorder(ADHD)
Disorder(PTSD) ADHD, without hyperactivity(ADD)
Minor Depression(MD) Panic Disorder(PD) ADHD, with hyperactivity(ADDH)
Irritable MD(IMD) Separation Anxiety(SA) ADHD, combined(ADDC)
Dysthymic Disorder(DD) Simple Phobic Disorder(SPD) ADHD, NOS(ADDN)
Irritable DD(IDD) Social Phobia(SP)
Depressive Disorder NOS Obsessive Compulsive Substance Abuse(SAB)
Disorder(OCD) Substance Dependence(SD)
Bipolar Depression, Mania Anxiety Disorder NOS
Hypomania
Bipolar Depression
Cyclothymia(CYCLO)
Bipolar Depression NOS
Psychoses Eating Disorders Other Disorders
Schizophrenia Anorexia Nervosa Schizotypal
Schizoaffective Disorder, depressed Bulimic Disorder Paranoid Disorder
Eating Disorder NOS Unspecified mental disorder
Schizoaffective Disorder, manic
Unspecified functional psychosis
Adjustment DisordersChild and Adolescent Psychiatry and Mental Health 2008, 2:15 http://www.capmh.com/content/2/1/15
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administered the Wechsler Abbreviated Scale of Intelli-
gence (WASI). IQ scores are available for 241 subjects
(70.5% of the sample). Socioeconomic status (SES) was
calculated on 314 families (91.8%) by Hollingshead 4
factor scale [19]. Other pertinent data collected included
proband prenatal and birth history, parental and teacher
rated SWAN ADHD scales [20], and parental self report
ADHD ratings. Bloods were also drawn from both parents
and ADHD probands for genotyping.
Data Analysis
Chi-square with continuity correction, Fisher exact proba-
bility, or binomial tests were used to analyze observed fre-
quency or dichotomous data. Analysis of variance was
used to test mean difference among continuous variables.
All analyses were two tailed. Corrections for multiple
comparisons were not made as the data analysis was
exploratory in nature; significant p values were set equal
to or less than 0.05. All analyses were done with SPSS
15.0.
Results
The sample consists of 342 Caucasian patients all with a
current diagnosis of ADHD. Within the sample there are
31 sibling pairs and 6 triple sibling groups comprising 62
and 18 patients respectively. This is approximately 24% of
the sample. Twins or triplets were not included. Birth
weight range was 5.5–12 lbs (mean 7.9 lbs; SD 1.1). IQ
scores ranged from 77 to 147 (mean 110.2, SD 14.2;
median 109.0). The mean SES raw score was 47.9 (SD
11.1) with a range from 18 to 66. The mean SES class was
2.0 (SD 0.9). None of these demographic parameters dif-
fered among the three main ADHD subtypes.
The subject's sex and age characteristics are shown in
Table 2. Although there are significantly more boys (72%)
than girls (28%) in each of the three main subtypes, their
mean ages within each subtype are similar. The ADDI sub-
jects were significantly older than those in the ADDH and
ADDC groups regardless of sex (F = 8.9, df = 5, p < 0.00).
The proportion of the three main ADHD subtypes was not
evenly distributed. There was a greater percent of the
Combined subtype (ADDC) (59.4%), than Inattentive
subtype (ADDI) (31.0%) which also was more frequent
than the Hyperactive subtype (ADDH) (9.1%). Two sub-
jects (0.6%) were diagnosed with ADDN. More boys and
fewer girls were in the ADDH group compared to the
ADDI group (x2 = 4.5, df = 2, p = 0.033). The sex ratios
were not significantly different in other comparisons
between the ADDC vs ADDH or the ADDC vs ADDI.
Tables 3, 4, 5 and 6 lists the concurrent co-morbid pat-
terns within the sample. It only includes those diagnoses
present. Diagnoses not present also reflect the clinical pat-
tern of these subjects. In the Affective Disorders there were
neither concurrent cases of endogenous, psychotic, irrita-
ble Major Depressive Disorder (MDD), nor any Depres-
sive Disorder NOS. There were no cases of any Bipolar
Disorder except Cyclothymia. There were no concurrent
Eating Disorders or Anxiety Disorder NOS. All Behavior
Disorders were present except Disruptive Behavior Disor-
der NOS. No Psychoses, Other Disorders, or Adjustment
Disorders occurred concurrently with ADHD. Diagnostic
patterns differed minimally between those present in the
last year (PE) versus the last week (LW). Fifteen of 20
MDD subjects (8 recovered, 5 remitted to MDDD; 5
remained active; 1 had a recurrent MD, and 1 remitted to
baseline DD) and 6 of 8 PTSD subjects were no longer
fully symptomatic from the PE to the LW evaluation. As
noted previously, actively depressed or manic patients
were excluded at intake.
In the sample as a whole, the most prevalent co-occurring
diagnoses were Oppositional Defiant Disorder
Table 2: Gender and age characteristics of ADHD sample
Male Female Total Sig
n(%) 247(72.2) 95(27.8) 342 M > F, p=.000
AGE:
mean(sd) 10.0(3.1) 10.6(3.3) 10.1(3.2) Ns
median 9.3 9.9 9.4
range 6.0–18.9 6.1–17.8 6.0–18.9
ADDC n(%) 149(73.4) 54(26.6) 203(59.4) M > F, p = 0.000
age(sd) 9.4(2.7) 10.0(3.3) 9.6(2.9) Ns
ADDI n(%) 69(65.1) 37(34.9) 106(31.0) M > F, p = 0.000
age(sd) 11.6(3.6)1 11.7(3.0)1 11.7(3.4)1 Ns
ADDH n(%) 27(87.1) 4(12.9) 31(9.1) M > F, p = 0.000
age(sd) 8.5(2.8) 8.2(1.5) 8.5(2.7) Ns
ADDN n(%) 2(100) 2(0.6)
age 12.0 12.0
ADDC: Combined type ADHD; ADDI: Inattentive ADHD; ADDH: Hyperactive ADHD;
ADDN: ADHD NOS; 1: sig. older than ADDC & ADDH (F = 21.7, df = 2, p < 0.00)Child and Adolescent Psychiatry and Mental Health 2008, 2:15 http://www.capmh.com/content/2/1/15
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(ODD:139, 40.6%), Minor Depression/Dysthmic Disor-
der (MDDD:74, 21.6%), and Generalized Anxiety Disor-
der (GAD:52, 15.2%). This pattern however varied when
co-morbid patterns were considered in the three individ-
ual diagnostic groups (i.e., mood, anxiety, behavior).
Among the MDDD group (n = 74), the most prevalent
diagnoses were ODD (48, 64.9%), ADDC (46, 62.2%),
and GAD (19, 25.7%). 32.2% of the total sample had at
least one anxiety disorder. Among those with AnyAD (n =
110), the most common disorders were ADDC (63,
57.3%), GAD (52: 47.3%), and ODD (48: 43.6%). 30%
(33) of the AnyAD group had MDDD. Those with ODD
(n = 139) most commonly had ADDC (103: 74.1%),
MDDD (48: 34.5%), and GAD (24: 17.4%). There were
no significant sex differences in any of these diagnostic
frequency patterns except that Separation Anxiety (SA)
was more common in girls than boys (13.7% vs 4.5%, x2
= 7.6, df = 1, p = .004).
Within the three main ADHD subtypes, the three most
prevalent comorbid patterns also varied. In ADDI (n =
106), 20.8% had MDDD, 20.8% has ODD, and 18.6%
had GAD. The most common diagnostic patterns in
ADDH (n = 31) were ODD (41.9%), GAD (22.6%), and
MDDD (19.4%). In ADDC (n = 203), the most prevalent
disorders were ODD (50.7%), MDDD (22.7%), and GAD
(12.3%). Within these three ADHD subtypes, MDDD and
GAD were equally prevalent. However, ODD was signifi-
cantly more prevalent in those with ADDC (50.7%) and
ADDH (41.9%) compared to those with ADDI (20.8%).
ODD was equally prevalent in those with ADDC and
ADDH. Of all comorbid diagnoses, only ODD exhibited a
different prevalence among the 3 ADHD subtypes.
The mean number of concurrent comorbid diagnoses in
the total sample is 2.1, inclusive of ADHD. 36.3% (124)
had only ADHD, 33.3% (114) had ADHD with one addi-
tional disorder, 18.7% (64) had two disorders, 8.2% (28)
had three disorders, 2.9% (10) had four disorders, and
two patients (0.6%) had five additional disorders besides
ADHD. ODD occurred alone in 51.8% (59), GAD in
13.2% (15), and MDDD in 12.3% (14) of those with one
additional diagnosis. 34.2% (39) only had AnyAD co-
occurring with ADHD. In those with two or more addi-
tional diagnoses (n = 104), ODD occurred in 76.9% (80),
MDDD in 57.7% (60), and GAD in 35.6%, (37). If Major
Depressive Disorder (MDD) and Cyclothymia (CYCLO)
are also included with the MDDD cohort, ODD and Any
Table 3: Comorbid Anxiety Disorders in Affective Disordersa
N(%) MDD MD IMD DD IDD MDDD CYCLO
342 5(1.5) 31(9.1) 3(0.9) 36(10.5) 4(1.2) 74(21.6) 2(0.6)
AD 20(5.8) 0 1(5.0) 1(5.0) 6(30.0)1 0 8(40.0) 0
GAD 52(15.2) 1(1.9) 8(15.4) 0 9(17.3) 2(3.8) 19(36.5)1 2(3.8)1
PTSD 2(0.6) 000 0 0 0 0
PD 2(0.6) 000 0 0 0 0
SA 24(7.0) 0 4(16.7) 0 2(8.3) 0 6(25.0) 0
SPD 26(7.6) 0 4(15.4) 0 4(15.4) 2(7.7)1 10(38.5)1 1(3.8)
SP 9(2.6) 0 0 0 2(22.2) 0 2(22.2) 0
OCD 11(3.2) 0 1(9.1) 0 1(9.1) 0 2(18.2) 0
AnyAD 110(32.2) 1(0.9) 14(12.7) 1(0.9) 16(14.5) 2(1.8) 33(30.0)1 2(1.8)
a. see Tb1 for diagnostic abbreviations; AnyAD: Any Anxiety Disorder;
1: significant co-occurrence, Fisher's Exact Test
Table 4: Comorbid Behavior Disorders in Affective Disordersa
N(%) MDD MD IMD DD IDD MDDD CYCLO
342 5(1.5) 31(9.1) 3(0.9) 36(10.5) 4(1.2) 74(21.6) 2(0.6)
ODD 139(40.6) 4(2.9) 15(10.8) 3(2.2) 26(18.7)1 4(2.9)1 48(34.5)1 2(1.4)
ADDI 106(31.0) 1(0.9) 12(11.3) 0 10(9.4) 0 22(20.8) 1(0.9)
ADDH 31(9.1) 0 3(9.7) 0 3(9.7) 0 6(19.4) 0
ADDC 203(59.4) 4(2.0) 16(7.9) 3(1.5) 23(11.3) 4(2.0) 46(22.7) 1(0.5)
ADDN 2(0.6) 000 0 0 0 0
CDSN 1(0.3) 0 0 0 1(100) 0 1(100) 0
SAB 6(1.8) 0 1(16.7) 0 0 0 1(16.7) 0
SD 3(0.9) 0 0 0 1(33.3) 0 1(33.3) 0
a. see Tb1 for diagnostic abbreviations; MDDD: Minor Depression/Dysthymic Disorder;
1: significant co-occurrence, Fisher's Exact TestChild and Adolescent Psychiatry and Mental Health 2008, 2:15 http://www.capmh.com/content/2/1/15
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Affective Disorder co-occur in 54 cases which are 15.8% of
the entire sample but represents 51.9% (54/104) of those
with 3 or more diagnoses. All affective disorders (except
Cyclothymia), GAD, SA and SPD were significantly more
prevalent in those with 3 or more diagnoses compared to
those with only 2 diagnoses. In the pure ADHD sample
(124), the rate of ADDI was 35.5%(44), ADDH 9.7%(12),
and ADDC 54.8%(68). This proportional pattern of
ADHD subtypes was similar to that of the remaining
group with 2 or more diagnoses.
Subjects with Panic Disorder (PD) were the youngest
(mean age 8.0) but there were only 2 cases. Subjects with
SA and ADDH were the next youngest diagnostic groups
(mean age 8.5). The oldest diagnostic group was the Sub-
stance Abuse Disorder/Substance Dependence (SAB/SD)
patients (mean age 16.5). Patients with SA or ADDH were
significantly younger than those patients without these
diagnoses. Those with SP, ADDI, ADDC, and SAB/SD
were significantly older than those without these diag-
noses. There were no significant age differences between
the boys and girls in any diagnostic group except for the
boys with SP being older than the girls with SP (12.6 vs
10.2). However, there were only two girls with SP. The
ADDH group were significantly younger than either the
ADDC or ADDI subjects (F = 21.7, df = 2, p = 0.00).
Given the high prevalence of ODD, the sample was
dichotomized into those with or without ODD and
comorbid characteristics reanalyzed. Those subjects with
ODD were significantly more likely to have MDDD, SPD,
ADDC and significantly less likely to have ADDI. Within
the Affective Disorder group, the significant correlation
with ODD was predominantly driven by DD, IDD, and
IMD. 64.9% (48/74) of MDDD subjects had ODD versus
34.0% of those without MDDD (x2 = 21.7, df = 1, p =
0.00).
Because the symptom of Irritability has taken center stage
in the comorbid diagnostic pattern of ADHD and Bipolar
Disorder in preadolescent children, its comorbid charac-
teristics were analyzed in this sample. 66 subjects (81.8%
Table 5: Comorbidity among Anxiety Disordersa
N(%) AD GAD PTSD PD SA SPD SP OCD
342 20(5.8) 52(15.2) 2(0.6) 2(0.6) 24(7.0) 26(7.6) 9(2.6) 11(3.2)
AD 20(5.8) --- 4(20.0) 0 0 0 1(5.0) 3(15.0)1 1(5.0)
GAD 52(15.2) 4(7.7) --- 0 1(1.9) 8(15.4)1 10(19.2)1 1(1.9) 2(3.8)
PTSD 2(0.6) 00 - - - 0 1 ( 5 0 . 0 ) 00 0
PD 2(0.6) 0 1(50.0) 0 --- 0 1(50.0) 0 0
SA 24(7.0) 08 ( 3 3 . 3 ) 1 1(4.2) 0 --- 6(25.0)1 2(8.3) 0
SPD 26(7.6) 1(3.8) 10(38.5)1 0 1(3.8) 6(23.1)1 --- 0 0
SP 9(2.6) 3(33.3)1 1(11.1) 0 0 2(22.2) 0 --- 0
OCD 11(3.2) 1(9.1) 2(18.2) 0 0 0 0 0 ---
AnyAD 110(32.2) 20(18.2) 52(47.3) 2(1.8) 2(1.8) 24(21.8) 26(23.6) 9(8.2) 11(10.0)
a. see Tb1 for diagnostic abbreviations; AnyAD: Any Anxiety Disorder;
1: significant co-occurrence, Fisher's Exact Test
Table 6: Comorbid Anxiety Disorders in Behavior Disordersa
N(%) ODD ADDI ADDH ADDC ADDN CDSN SAB SD
342 139(40.6) 106(31.0) 31(9.1) 203(59.4) 2(0.6) 1(0.3) 6(1.8) 3(0.9)
AD 20(5.8) 7(35.0) 9(45.0) 1(5.0) 10(50.0) 0 0 0 0
GAD 52(15.2) 24(46.2) 19(36.5) 7(13.5) 25(48.1) 1(1.9) 0 0 1(1.9)
PTSD 2(0.6) 2(100) 0 0 2(100) 0 0 1(50.0)1 1(50.0)1
PD 2(0.6) 1(50.0) 0 1(50.0) 1(50.0) 0 0 0 0
SA 24(7.0) 13(54.2) 5(20.8) 1(4.2) 18(75.0) 0 0 0 0
SPD 26(7.6) 16(61.5)1 4(15.4) 4(15.4) 17(65.4) 1(3.8) 0 0 0
SP 9(2.6) 3(33.3) 4(44.4) 0 5(55.6) 0 0 0 0
OCD 11(3.2) 2(18.2) 3(27.3) 1(9.1) 7(63.6) 0 0 0 0
AnyAD 110(32.2) 48(43.6) 36(32.7) 9(8.2) 63(57.3) 2(1.8) 0 1(0.9) 2(1.8)
a. see Tb1 for diagnostic abbreviations; AnyAD: Any Anxiety Disorder;
1: significant co-occurrence, Fisher's Exact TestChild and Adolescent Psychiatry and Mental Health 2008, 2:15 http://www.capmh.com/content/2/1/15
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prepubertal; 18.2% adolescent) either had subjective
(from the Depressive K-SADS module) or overt (from the
Mania module) Irritability. This represents 19.3% of the
entire sample of ADHD subjects. Only 7 subjects had con-
current subjective and overt Irritability. Irritability was sig-
nificantly associated with all of the Affective Disorder
subtypes. In the Anxiety Disorder group, it was signifi-
cantly associated with Avoidant Disorder; and, in the
Behavior Disorder group it was significantly associated
with ODD and ADDC. Within the Irritable group, 66.7%
(44/66) have MDDD, 71.2% (47/66) have ADDC, and
80.3% (53/66) have ODD. This specific comorbid triad
(i.e., MDDD, ODD, ADDC) represents 10.8% (37/342) of
the entire sample. 31 of these 37 cases (83.8%) are those
with symptomatic Irritability. These 31 cases represent
almost half of those with Irritability (31/66, 47.0%).
Discussion
Although the comorbid frequencies in this report do not
reflect a naturalistic sample, these diagnostic patterns are
quite similar to prior clinical studies reflecting diagnoses
endorsed by both child and parent informants. This data
set however includes the broadest age range and the most
extensive description of concurrent comorbidity of any
study which is based on summary data from both the par-
ent and child regardless of the subject's age.
Over 1/3rd of cases had pure ADHD. These findings are
similar to those reported in the MTA study, based on
parental DISC reports, in a comparable clinical cohort
which reported a 31.8%, 6 month prevalence rate of pure
ADHD, although from a younger age (mean age 8.5 years;
range 7.0 to 9.9) and mixed racial sample of only ADDC
subjects [10]. The proportion of pure ADHD cases within
the ADDC sample from this study was 33.5% (68/203).
Our data does diverge from a report in a general Swedish
school age population that suggested that pure ADHD
was rare [21]. This stands out as increased rates of comor-
bidity are expected in a clinic sample such as this. How-
ever, the Swedish group had a small sample of ADHD
subjects, including children with various developmental
disabilities who were excluded from this study.
ADDH represents less than 10% of the total sample of
ADHD subjects. This rate is lower than reported epidemi-
ological frequencies yet ADDH was still the least prevalent
of the three subtypes in such samples [22,23]. In a clinical
outpatient sample assessing lifetime comorbidity from
Biederman's group [24], the ADHD subtype frequencies
were almost identical to those reported in this study
(ADDC: 61% vs 59%; ADDI: 30% vs 31%; ADDC: 9% vs
9%, respectively). The age pattern was also similar as the
ADDI were the oldest, the ADDH the youngest while the
ADDC were intermediate in age. The male/female ratio
was approximately 3 to 1 in each study for the total sam-
ple, ADDI and ADDC.
ADDH and ADDC are dominated by ODD with a 49.6%
(116/234) combined comorbidity rate while ADDI has a
more uniform comorbid pattern among affective, anx-
ious, and behavior syndromes. ODD pervasiveness in
ADDH/ADDC is further seen as it is the overwhelming
comorbidity occurring in nearly 70% (51/74) of those
with only one additional diagnosis. Affective and Anxious
disorders only co-occur as a second diagnosis in approxi-
mately 6.8% and 23.0% respectively of the combined
ADDH/ADDC subtypes with one additional diagnosis.
These co-occurrence patterns between ADHD and affec-
tive, anxious and behavior disorders partially validate
Angold's analysis [1] which noted a more highly signifi-
cant odds ratio pairing between ADHD and CD/ODD
than ADHD and Depressive or ADHD and Anxiety disor-
ders. His analysis however did not differentiate among the
ADHD subtypes and analyzed epidemiological samples.
The pairing of affective, anxious and behavior disorders
significantly differed between the ADD and ADDH/
ADDC in this clinical sample since AnyAD (x2 = 9.6, df =
1, p = 0.002,) and AnyDep (x2 = 4.9, df = 1, p = 0.028)
were likely paired with ADD while ODD (x2 = 22.1, df = 1,
p = 0.00) was more likely paired with ADDH/ADDC.
The high co-occurrence of an affective disorder with
ADHD is reported in numerous settings [25,26] and in a
5 year prospective outcome study of ADHD girls [7], yet
most of these studies refer to life time or prospective co-
occurrence. The high prevalence of concurrent MDDD in
this cohort is significant particularly since actively
depressed cases were excluded from this study as was low
birth weight which in itself could account for higher rates
of depression in girls [27]. It suggests that Minor Depres-
sion and Dysthmia may be a more significant morbid fac-
tor in the disability of ADHD. The higher prevalence of
affective disturbances in females was not noted here but
this pattern emerges by the early teen years which is older
than the mean age of this sample [28].
The finding that Irritability as a symptom was highly asso-
ciated with MDDD and ODD is not surprising since it is
part of the diagnostic domain of Affective Disorders and
ODD [29]. Angold et al have shown the significant co-
occurrence of these diagnoses with ADHD [1]. However
what seems unique here is the greater likelihood of it
occurring in the preadolescent child linked with a diag-
nostic triad of MDDD, ODD, and ADDC. This finding
compliments the previously reported link of Irritability
with ODD, MDDD and ADHD in a group of depressed
and anxious adolescents [30]. Vance et al. [31] have also
noted that ADDC and DD significantly predicted ODDChild and Adolescent Psychiatry and Mental Health 2008, 2:15 http://www.capmh.com/content/2/1/15
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symptomatology in a sample of preadolescent ADDC
children chosen to exclude comorbid MDD.
In the present sample of 342 subjects, Irritability occurred
in 20% (54/272) of the preadolescents and in 17% (12/
70) of the adolescent subjects. However within the Irrita-
ble subjects themselves, 81.8% (54/66) were preadoles-
cents. It may be that it is this concurrent comorbid triad
with irritability is being over diagnosed as the prepubertal
Bipolar child. This data set's exclusion of Bipolarity only
adds more weight to this hypothesis. Whether this subset
of ADHD patients represents an enriched future Bipolar
core can only be evaluated through follow-up studies.
Nonetheless, there are current reports identifying ODD
and ADHD are more prevalent in youths with Irritable
Bipolar NOS [32].
Limitations
This clinical sample does not represent the general popu-
lation of clinically referred ADHD youths since the study
required the participation of both biological parents and
it was limited to Caucasians. Its comorbid patterns could
diverge from ADHD youths growing up in less-intact fam-
ilies as well as ethnically mixed ADHD samples. However,
this approach was necessitated by the primary genetic
aims of this study. The young mean age also implies that
many subjects have not passed through syndrome specific
age of onset time frames. This was most notable in the
same sex prevalence of MDDD. The sample also excluded
obvious active cases of both Major Depressive and Bipolar
disorders so it can not further elucidate characteristics of
the Bipolar/ADHD debate.
The majority of the K-SADS IVR interviews were com-
pleted by one rater which could introduce an information
collection bias to this data set. Also, the K-SADS does not
diagnoses learning disorders which can be co-morbid in
20–25% of ADHD subjects [33].
Clinical Implications
Almost 2/3rd of ADHD children have at least one addi-
tional impairing diagnosis. It is all too easy to overlook
this pattern and focus treatment solely on ADHD. As
noted in the MTA study, specific treatment combinations
may be more efficacious in certain comorbid patterns
[10]. It also is clear that ADDC is the most prevalent
ADHD subtype in clinical cohorts while ADDI is the most
prevalent in epidemiological samples [22,23].
The comorbidities described here reflect that occurring
within a selected ADHD sample chosen for a genetic anal-
ysis. It would be inappropriate therefore to interpret these
rates suggesting they are "true" comorbid patterns in other
disorders since the rate of ADHD is 100% within every
diagnosis recorded in this data set.
The clinician should be aware that Minor Depression/
Dysthymia is common in ADHD and not be quick to dis-
miss dysphoric states as adverse events of stimulant treat-
ment or the demoralization of having a significantly
debilitating illness.
The concurrent comorbid pattern displayed by this ADHD
cohort generally corresponds with previously reported
ADHD clinical samples. This suggests this data set is suffi-
ciently representative of the ADHD clinical population to
serve as a valid sample for genetic analysis. Concurrent
comorbid analysis of the ADHD population may allow
for a more comprehensive understanding of the vicissi-
tude of this syndrome and assist in identifying potential
endophenotypes. Phenotyping data from this study has
been submitted to the NIMH repository. Genotyping data
will also be submitted upon completion of study.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JE participated in study design, subject recruitment, phe-
notype ascertainment, data analyses and interpretation.
PJA participated in study design, data analyses and inter-
pretation. WB participated in study design, data analyses
and interpretation. All authors read and approved the
final manuscript.
Acknowledgements
This research is supported by NIMH (K23MH066275-01), CTR(UL1-RR-
024134). We want to thank all participating families, the referring clinicians 
and Tamika Scott, research coordinator.
References
1. Angold A, Costello EJ, Erkanli A: Comorbidity.  Journal of child psy-
chology and psychiatry, and allied disciplines 1999, 40(1):57-87.
2. Caron C, Rutter M: Comorbidity in child psychopathology:
concepts, issues and research strategies.  Journal of child psychol-
ogy and psychiatry, and allied disciplines 1991, 32(7):1063-1080.
3. van Praag HM: Over the mainstream: diagnostic requirements
for biological psychiatric research.  Psychiatry Res 1997,
72(3):201-212.
4. Barkley RA: Attention-Deficit Hyperactivity Disorder. A
Handbook for Diagnosis and Treatment.  3rd Edition edition.
New York , Guilford Press; 2006. 
5. Group MTAC: A 14-month randomized clinical trial of treat-
ment strategies for attention-deficit/hyperactivity disorder.
The MTA Cooperative Group. Multimodal Treatment Study
of Children with ADHD.  Arch Gen Psychiatry 1999,
56(12):1073-1086.
6. Busch B, Biederman J, Cohen LG, Sayer JM, Monuteaux MC, Mick E,
Zallen B, Faraone SV: Correlates of ADHD among children in
pediatric and psychiatric clinics.  Psychiatr Serv 2002,
53(9):1103-1111.
7. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Klein KL,
Price JE, Faraone SV: Psychopathology in females with atten-
tion-deficit/hyperactivity disorder: a controlled, five-year
prospective study.  Biol Psychiatry 2006, 60(10):1098-1105.
8. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin
D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T,
Kraus I, Perrin J: A prospective 4-year follow-up study of atten-
tion-deficit hyperactivity and related disorders.  Arch Gen Psy-
chiatry 1996, 53(5):437-446.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Child and Adolescent Psychiatry and Mental Health 2008, 2:15 http://www.capmh.com/content/2/1/15
Page 9 of 9
(page number not for citation purposes)
9. Ambrosini PJ: Historical development and present status of
the schedule for affective disorders and schizophrenia for
school-age children (K-SADS).  J Am Acad Child Adolesc Psychiatry
2000, 39(1):49-58.
10. Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff
HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR,
Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson
JM, Wells KC, Wigal T, Vitiello B: ADHD comorbidity findings
from the MTA study: comparing comorbid subgroups.  J Am
Acad Child Adolesc Psychiatry 2001, 40(2):147-158.
11. Eiraldi RB, Power TJ, Nezu CM: Patterns of comorbidity associ-
ated with subtypes of attention-deficit/hyperactivity disor-
der among 6- to 12-year-old children.  J Am Acad Child Adolesc
Psychiatry 1997, 36(4):503-514.
12. Willcutt EG, Pennington BF, Chhabildas NA, Friedman MC, Alexan-
der J: Psychiatric comorbidity associated with DSM-IV
ADHD in a nonreferred sample of twins.  J Am Acad Child Adolesc
Psychiatry 1999, 38(11):1355-1362.
13. Eiraldi RB, Power TJ, Karustis JL, Goldstein SG: Assessing ADHD
and comorbid disorders in children: the Child Behavior
Checklist and the Devereux Scales of Mental Disorders.  Jour-
nal of clinical child psychology 2000, 29(1):3-16.
14. Power TJ, Costigan TE, Eiraldi RB, Leff SS: Variations in anxiety
and depression as a function of ADHD subtypes defined by
DSM-IV: do subtype differences exist or not?  Journal of abnor-
mal child psychology 2004, 32(1):27-37.
15. Takahashi K, Miyawaki D, Suzuki F, Mamoto A, Matsushima N, Tsuji
H, Horino A, Ballas PA, Kiriike N: Hyperactivity and comorbidity
in Japanese children with attention-deficit/hyperactivity dis-
order.  Psychiatry and clinical neurosciences 2007, 61(3):255-262.
16. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK: The world-wide
distribution of allele frequencies at the human dopamine D4
receptor locus.  Hum Genet 1996, 98(1):91-101.
17. Spitzer RL, Endicott J, Robins E: Research diagnostic criteria:
rationale and reliability.  Arch Gen Psychiatry 1978, 35(6):773-782.
18. Association AP: Diagnostic and Statistical Manual of Mental
Disorders. 4th ed. DSM-IV.  4th edition. Washington, DC , Amer-
ican Psychiatric Association; 1994. 
19. Hollingshead AB: Four Factor Index of Social Status.  New
Haven ; 1975. 
20. Hay DA, Bennett KS, Levy F, Sergeant J, Swanson J: A twin study of
attention-deficit/hyperactivity disorder dimensions rated by
the strengths and weaknesses of ADHD-symptoms and nor-
mal-behavior (SWAN) scale.  Biol Psychiatry 2007, 61(5):700-705.
21. Kadesjo B, Gillberg C: The comorbidity of ADHD in the general
population of Swedish school-age children.  J Child Psychol Psy-
chiatry 2001, 42(4):487-492.
22. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK,
Kahn RS: Prevalence, recognition, and treatment of atten-
tion-deficit/hyperactivity disorder in a national sample of US
children.  Arch Pediatr Adolesc Med 2007, 161(9):857-864.
23. Smalley SL, McGough JJ, Moilanen IK, Loo SK, Taanila A, Ebeling H,
Hurtig T, Kaakinen M, Humphrey LA, McCracken JT, Varilo T, Yang
MH, Nelson SF, Peltonen L, Jarvelin MR: Prevalence and psychiat-
ric comorbidity of attention-deficit/hyperactivity disorder in
an adolescent Finnish population.  J Am Acad Child Adolesc Psychi-
atry 2007, 46(12):1575-1583.
24. Faraone SV, Biederman J, Weber W, Russell RL: Psychiatric, neu-
ropsychological, and psychosocial features of DSM-IV sub-
types of attention-deficit/hyperactivity disorder: results
from a clinically referred sample.  J Am Acad Child Adolesc Psychi-
atry 1998, 37(2):185-193.
25. Biederman J, Munir K, Knee D, Armentano M, Autor S, Waternaux
C, Tsuang M: High rate of affective disorders in probands with
attention deficit disorder and in their relatives: a controlled
family study.  Am J Psychiatry 1987, 144(3):330-333.
26. Biederman J, Faraone SV, Keenan K, Tsuang MT: Evidence of famil-
ial association between attention deficit disorder and major
affective disorders.  Arch Gen Psychiatry 1991, 48(7):633-642.
27. Costello EJ, Worthman C, Erkanli A, Angold A: Prediction from
low birth weight to female adolescent depression: a test of
competing hypotheses.  Arch Gen Psychiatry 2007, 64(3):338-344.
28. Wade TJ, Cairney J, Pevalin DJ: Emergence of gender differences
in depression during adolescence: national panel results
from three countries.  J Am Acad Child Adolesc Psychiatry 2002,
41(2):190-198.
29. Mick E, Spencer T, Wozniak J, Biederman J: Heterogeneity of irri-
tability in attention-deficit/hyperactivity disorder subjects
with and without mood disorders.  Biol Psychiatry 2005,
58(7):576-582.
30. Ambrosini PJ, Myers GM, Bianchi MD, Metz C: Irritable and
depressed mood:  Are they synonymous?: San Diego, CA. 
American Psychiatric Association; 1997:187. 
31. Vance A, Sanders M, Arduca Y: Dysthymic disorder contributes
to oppositional defiant behaviour in children with Attention
Deficit Hyperactivity Disorder, combined type (ADHD-CT).
J Affect Disord 2005, 86(2-3):329-333.
32. Masi G, Perugi G, Millepiedi S, Mucci M, Pari C, Pfanner C, Berloffa S,
Toni C: Clinical implications of DSM-IV subtyping of bipolar
disorders in referred children and adolescents.  J Am Acad Child
Adolesc Psychiatry 2007, 46(10):1299-1306.
33. Pliszka SR: Patterns of psychiatric comorbidity with attention-
deficit/hyperactivity disorder.  Child Adolesc Psychiatr Clin N Am
2000, 9(3):525-40, vii.